Note 9: Investments in associates and joint ventures

At year-end 2015, the carrying value of investments in associates amounted to €107 million (2014: €100 million) and in joint ventures €58 million (2014: €83 million). In 2015, the results from associates and joint ventures amounted to a profit of €17 million (2014: €21 million).

No significant contingent liabilities exist related to associates and joint ventures.

In 2015, we acquired the remaining 50 percent stake in Delesto B.V. and obtained control. As a result Delesto B.V. changed from a joint venture into a consolidated company.

The most significant associates and joint ventures of AkzoNobel are: Metlac Holdings Brl (49 percent), Metlac Spa (44 percent), Eka Chile SA (50 percent), Delamine B.V. (50 percent), Fort Amanda Specialties LLC (50 percent) and I.C. Insurance Holdings Ltd (49 percent).

None of the associates and joint ventures are considered individually material to the group.

Combined financial information of our share in associates and joint ventures

 

 

 

 

 

 

 

 

 

 

 

Associates

 

Joint ventures

In € millions

 

2014

 

2015

 

2014

 

2015

 

 

 

 

 

 

 

 

 

Condensed statement of income

 

 

 

 

 

 

 

 

Revenue

 

93

 

103

 

220

 

126

Profit before tax

 

19

 

18

 

9

 

12

 

 

 

 

 

 

 

 

 

Profit from continuing operations

 

13

 

11

 

8

 

6

Other

 

1

 

1

 

4

 

2

Total comprehensive income

 

14

 

12

 

12

 

8

 

 

 

 

 

 

 

 

 

Condensed balance sheet

 

 

 

 

 

 

 

 

Non-current assets

 

57

 

60

 

44

 

42

Current assets

 

84

 

85

 

76

 

46

Total assets

 

141

 

145

 

120

 

88

Shareholders’ equity

 

100

 

107

 

83

 

58

Non-current liabilities

 

14

 

4

 

11

 

11

Current liabilities

 

27

 

34

 

26

 

19

Total liabilities and equity

 

141

 

145

 

120

 

88

Comprehensive income

The change in equity during a period resulting from transactions and other events, other than those changes resulting from transactions with shareholders in their capacity as shareholders.